Portland, OR — 11/29/2017 — These Veterinary/Animal vaccines can be given subcutaneously (under the skin) or intramuscularly (into the muscle) to animal. The aim of veterinary vaccines is to improve livestock production in a cost effective manner. The rise in the incidences of zoonotic diseases are affecting humans and has led to increased interest in companion animal vaccines. Advancement in this area is mainly due to emergence of new zoonotic diseases, investment by government bodies and increased expenditures on animal health by pet lovers.
In recent years' veterinary vaccines have made much impact on human health, welfare and production by developing novel vaccines which can target dangerous zoonotic diseases such as E. coli O157:H7, a food borne disease that can lead to HUS and kidney failure. Moreover, due to novel research in the field, expansion in the range of veterinary vaccines and formulations of adjuvants and reduction of pharmaceutical residuals in the human food chain will propel the growth of veterinary vaccines market. However, persistent economic slowdown, rising costs of storage and maintenance and the increase in the vegetarian population are major factors constituting to restraints of market. With improvement in costs, more investments in animal health and skilled expertise this market could have lucrative opportunities of growth.
Early buyers will receive 20% customization on this report
Get sample PDF brochure of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/1056
The report segments the market on the basis of products, diseases, technologies and regions. On the basis of products market is categorized into companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. On the basis of technology, market is further segmented into inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines and subunit vaccines. In terms of disease, it is classified to livestock diseases, aquaculture, poultry, companion diseases and others. Geographically, the market is analyzed in North America, Europe, Asia-Pacific and LAMEA.
Many companies are working in development of veterinary vaccines by undergoing collaboration between research institutions and companies, product approvals and launches, licensing agreements and partnerships amongst companies and augmented R&D investment on veterinary vaccines for instance, Zoetis announces product approval in 2013 for Rui Lan An Swine Vaccine for curing highly pathogenic porcine reproductive and respiratory syndrome (HP PRRS)
KEY MARKET BENEFITS:
– This report provides an extensive analysis of the current and emerging market trends and dynamics in the global veterinary vaccines market.
– Geographically, the veterinary vaccines are analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.
– This study evaluating competitive landscape and value chain has been taken into account to help in understanding the competitive environment across the geographies.
– Comprehensive analysis of factors that drive and restrict the growth of the global veterinary vaccines market is provided. For instance, increasing incidence of zoonotic disease and rising expenditure on animal health drives the market growth while cost of pet care and storage issues forms the restraints of market.
Powered by WPeMatico